PT779076E - Peptidos, um metodo para a sua obtencao e um composto farmaceutico om base nestes - Google Patents
Peptidos, um metodo para a sua obtencao e um composto farmaceutico om base nestesInfo
- Publication number
- PT779076E PT779076E PT95924554T PT95924554T PT779076E PT 779076 E PT779076 E PT 779076E PT 95924554 T PT95924554 T PT 95924554T PT 95924554 T PT95924554 T PT 95924554T PT 779076 E PT779076 E PT 779076E
- Authority
- PT
- Portugal
- Prior art keywords
- cys
- ala
- orn
- lys
- arg
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- -1 D-Hyp Chemical compound 0.000 abstract 12
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 5
- AHLPHDHHMVZTML-SCSAIBSYSA-N D-Ornithine Chemical compound NCCC[C@@H](N)C(O)=O AHLPHDHHMVZTML-SCSAIBSYSA-N 0.000 abstract 3
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N D-alpha-Ala Natural products CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 abstract 3
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical compound OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 abstract 3
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 abstract 3
- DCXYFEDJOCDNAF-UWTATZPHSA-N D-Asparagine Chemical compound OC(=O)[C@H](N)CC(N)=O DCXYFEDJOCDNAF-UWTATZPHSA-N 0.000 abstract 2
- XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 abstract 2
- AGPKZVBTJJNPAG-RFZPGFLSSA-N D-Isoleucine Chemical compound CC[C@@H](C)[C@@H](N)C(O)=O AGPKZVBTJJNPAG-RFZPGFLSSA-N 0.000 abstract 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 abstract 2
- ONIBWKKTOPOVIA-SCSAIBSYSA-N D-Proline Chemical compound OC(=O)[C@H]1CCCN1 ONIBWKKTOPOVIA-SCSAIBSYSA-N 0.000 abstract 2
- MTCFGRXMJLQNBG-UWTATZPHSA-N D-Serine Chemical compound OC[C@@H](N)C(O)=O MTCFGRXMJLQNBG-UWTATZPHSA-N 0.000 abstract 2
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 abstract 2
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 abstract 2
- HNDVDQJCIGZPNO-RXMQYKEDSA-N D-histidine Chemical compound OC(=O)[C@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-RXMQYKEDSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 abstract 2
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 abstract 2
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 abstract 2
- AYFVYJQAPQTCCC-STHAYSLISA-N D-threonine Chemical compound C[C@H](O)[C@@H](N)C(O)=O AYFVYJQAPQTCCC-STHAYSLISA-N 0.000 abstract 2
- QIVBCDIJIAJPQS-SECBINFHSA-N D-tryptophane Chemical compound C1=CC=C2C(C[C@@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-SECBINFHSA-N 0.000 abstract 2
- OUYCCCASQSFEME-MRVPVSSYSA-N D-tyrosine Chemical compound OC(=O)[C@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-MRVPVSSYSA-N 0.000 abstract 2
- KZSNJWFQEVHDMF-SCSAIBSYSA-N D-valine Chemical compound CC(C)[C@@H](N)C(O)=O KZSNJWFQEVHDMF-SCSAIBSYSA-N 0.000 abstract 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 2
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 abstract 2
- 150000001408 amides Chemical class 0.000 abstract 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 1
- OABOXRPGTFRBFZ-IMJSIDKUSA-N Cys-Cys Chemical compound SC[C@H](N)C(=O)N[C@@H](CS)C(O)=O OABOXRPGTFRBFZ-IMJSIDKUSA-N 0.000 abstract 1
- ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 abstract 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- 125000000174 L-prolyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])[C@@]1([H])C(*)=O 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- 125000000510 L-tryptophano group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C(C([H])([H])[C@@]([H])(C(O[H])=O)N([H])[*])C2=C1[H] 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 206010052428 Wound Diseases 0.000 abstract 1
- 208000027418 Wounds and injury Diseases 0.000 abstract 1
- 230000001195 anabolic effect Effects 0.000 abstract 1
- 150000008064 anhydrides Chemical class 0.000 abstract 1
- UCMIRNVEIXFBKS-UHFFFAOYSA-N beta-alanine Chemical compound NCCC(O)=O UCMIRNVEIXFBKS-UHFFFAOYSA-N 0.000 abstract 1
- 230000001764 biostimulatory effect Effects 0.000 abstract 1
- 230000037396 body weight Effects 0.000 abstract 1
- 239000003054 catalyst Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000010276 construction Methods 0.000 abstract 1
- 108010004073 cysteinylcysteine Proteins 0.000 abstract 1
- 210000002615 epidermis Anatomy 0.000 abstract 1
- 150000002170 ethers Chemical class 0.000 abstract 1
- 230000035876 healing Effects 0.000 abstract 1
- 230000000945 opiatelike Effects 0.000 abstract 1
- 229910052763 palladium Inorganic materials 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 230000008439 repair process Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1019—Tetrapeptides with the first amino acid being basic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU9494024278A RU2067000C1 (ru) | 1994-06-29 | 1994-06-29 | Пептид и способ его получения |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT779076E true PT779076E (pt) | 2005-07-29 |
Family
ID=20157803
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT95924554T PT779076E (pt) | 1994-06-29 | 1995-06-27 | Peptidos, um metodo para a sua obtencao e um composto farmaceutico om base nestes |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP0779076B1 (pt) |
| JP (1) | JP3668950B2 (pt) |
| CN (1) | CN1165336C (pt) |
| AT (1) | ATE290547T1 (pt) |
| AU (1) | AU693576B2 (pt) |
| CA (1) | CA2193969C (pt) |
| DE (1) | DE69534061T2 (pt) |
| DK (1) | DK0779076T3 (pt) |
| ES (1) | ES2239760T3 (pt) |
| PT (1) | PT779076E (pt) |
| RU (1) | RU2067000C1 (pt) |
| WO (1) | WO1996002267A1 (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5868728A (en) * | 1995-02-28 | 1999-02-09 | Photogenesis, Inc. | Medical linear actuator for surgical delivery, manipulation, and extraction |
| RU2107691C1 (ru) * | 1995-03-02 | 1998-03-27 | Дейгин Владислав Исакович | Пептид и способ его получения |
| EP0838472A4 (en) * | 1995-06-21 | 2000-02-02 | Asahi Chemical Ind | LOW DENSITY LIPOPROTEIN BINDING PEPTIDES |
| EA001000B1 (ru) * | 1995-09-11 | 2000-08-28 | Дайити Фармасьютикал Ко., Лтд. | Производные пептидов |
| US5965701A (en) * | 1997-12-23 | 1999-10-12 | Ferring Bv | Kappa receptor opioid peptides |
| AU2969800A (en) * | 1999-01-22 | 2000-08-07 | Pharmacore, Inc. | A method for the synthesis of compounds of formula 1 and derivatives thereof |
| US7473426B2 (en) | 2001-02-27 | 2009-01-06 | Yun Seok Choe | Method for selectively inhibiting reuptake of serotonin and norepinephrine using yeast extract |
| WO2002067959A1 (en) * | 2001-02-27 | 2002-09-06 | Neurotide Co., Ltd. | Peptide derived from yeast having activities as anti-tsress, anti-fatigue and brain neurotrophic factor and relaxing premenstrual syndrome and menstrual pain, and prepairing process thereof |
| RU2298921C1 (ru) * | 2005-10-04 | 2007-05-20 | Закрытое Акционерное Общество "Центр "Пептос" | Способ стимуляции развития осетровых рыб |
| US7842662B2 (en) | 2006-11-10 | 2010-11-30 | Cara Therapeutics, Inc. | Synthetic peptide amide dimers |
| CN101627049B (zh) | 2006-11-10 | 2012-09-05 | 卡拉治疗学股份有限公司 | 合成酞酰胺 |
| US7713937B2 (en) | 2006-11-10 | 2010-05-11 | Cara Therapeutics, Inc. | Synthetic peptide amides and dimeric forms thereof |
| US8906859B2 (en) | 2006-11-10 | 2014-12-09 | Cera Therapeutics, Inc. | Uses of kappa opioid synthetic peptide amides |
| US8236766B2 (en) | 2006-11-10 | 2012-08-07 | Cara Therapeutics, Inc. | Uses of synthetic peptide amides |
| EP3087093B1 (en) * | 2013-12-27 | 2021-11-10 | Stealth Biotherapeutics Corp | Pharmaceutically relevant aromatic-cationic peptides |
| EP3265109B1 (en) | 2015-03-06 | 2020-10-21 | Stealth BioTherapeutics Corp | Processes for preparing pharmaceutically relevant peptides |
| EP3388089B1 (en) * | 2015-12-10 | 2022-05-18 | Menicon Co., Ltd. | Peptide composition |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL8005121A (nl) * | 1979-09-20 | 1981-03-24 | Erba Farmitalia | Biologisch actieve peptiden. |
| IE56021B1 (en) * | 1982-10-13 | 1991-03-27 | Akzo Nv | Peptides |
| JPS59181293A (ja) * | 1983-03-31 | 1984-10-15 | Kyowa Hakko Kogyo Co Ltd | 新規生理活性蛋白性物質 |
| FR2546756B1 (fr) * | 1983-06-03 | 1985-11-29 | Centre Nat Rech Scient | Nouveaux derives immunostimulants, leur preparation et leur application comme medicament |
| GB2146026A (en) * | 1983-09-07 | 1985-04-11 | Tanabe Seiyaku Co | Peptides and process for preparing the same |
| DE3435727A1 (de) * | 1984-09-28 | 1986-04-10 | Victor Dipl.-Chem. Dr.med. 6200 Wiesbaden Brantl | Pharmakologisch aktive peptide |
| DE3841761A1 (de) * | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
| DE3841763A1 (de) * | 1988-12-12 | 1990-06-13 | Basf Ag | Neue tnf-peptide |
| SE9300012D0 (sv) * | 1993-01-05 | 1993-01-05 | Astra Ab | New peptides |
-
1994
- 1994-06-29 RU RU9494024278A patent/RU2067000C1/ru active
-
1995
- 1995-06-27 DE DE69534061T patent/DE69534061T2/de not_active Expired - Lifetime
- 1995-06-27 CN CNB951943820A patent/CN1165336C/zh not_active Expired - Fee Related
- 1995-06-27 DK DK95924554T patent/DK0779076T3/da active
- 1995-06-27 EP EP95924554A patent/EP0779076B1/en not_active Expired - Lifetime
- 1995-06-27 PT PT95924554T patent/PT779076E/pt unknown
- 1995-06-27 JP JP50356096A patent/JP3668950B2/ja not_active Expired - Fee Related
- 1995-06-27 AT AT95924554T patent/ATE290547T1/de not_active IP Right Cessation
- 1995-06-27 AU AU29002/95A patent/AU693576B2/en not_active Ceased
- 1995-06-27 ES ES95924554T patent/ES2239760T3/es not_active Expired - Lifetime
- 1995-06-27 CA CA2193969A patent/CA2193969C/en not_active Expired - Fee Related
- 1995-06-27 WO PCT/RU1995/000138 patent/WO1996002267A1/ru not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0779076A4 (en) | 1999-03-17 |
| CA2193969C (en) | 2010-11-30 |
| RU2067000C1 (ru) | 1996-09-27 |
| DE69534061T2 (de) | 2006-04-13 |
| CA2193969A1 (en) | 1996-02-01 |
| AU693576B2 (en) | 1998-07-02 |
| DE69534061D1 (de) | 2005-04-14 |
| WO1996002267A1 (en) | 1996-02-01 |
| AU2900295A (en) | 1996-02-16 |
| ATE290547T1 (de) | 2005-03-15 |
| HK1012551A1 (en) | 1999-08-06 |
| ES2239760T3 (es) | 2005-10-01 |
| CN1165336C (zh) | 2004-09-08 |
| CN1159758A (zh) | 1997-09-17 |
| EP0779076A1 (en) | 1997-06-18 |
| DK0779076T3 (da) | 2005-07-11 |
| JP3668950B2 (ja) | 2005-07-06 |
| JP2001503011A (ja) | 2001-03-06 |
| EP0779076B1 (en) | 2005-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT779076E (pt) | Peptidos, um metodo para a sua obtencao e um composto farmaceutico om base nestes | |
| KR0139632B1 (ko) | 브라디키닌 길항 작용을 갖는 펩티드 | |
| UA48974C2 (uk) | Пептид і спосіб його одержання | |
| RU94024278A (ru) | Пептид и способ его получения | |
| RU95108559A (ru) | Пептид и способ его получения | |
| KR840002772A (ko) | 뇌하수체 성장호르몬 유리작용을 지닌 펩타이드의 합성방법 | |
| LV11993A (lv) | Peptidi un to iegusanas panemiens | |
| KR910009730A (ko) | 펩티드 | |
| RU2006111491A (ru) | Новые противоопухолевые соединения | |
| EP0212912A2 (en) | Calcitonin analogs with C-therminal D-amino acid substituents | |
| FR2364889A1 (fr) | Nouveaux derives encephaliniques a la methionine | |
| ES536117A0 (es) | Un procedimiento para preparar heptapeptidos y hexapeptidos ciclicos antagonistas de la vasopresina | |
| EP0189326A3 (en) | Derivatives of arginine vasopressin antagonists | |
| EP0175323A2 (en) | Biologically active peptides, processes for preparing them and pharmaceutical compositions | |
| JPWO2022204305A5 (pt) | ||
| TH2820B (th) | เพพไทด์สังเคราะห์ที่แสดงฤทธิ์ปลดปล่อยฮอร์โมนช่วยการเติบโตของพิทูอิทารี | |
| TH1762A (th) | เพพไทด์สังเคราะห์ที่แสดงฤทธิ์ปลดปล่อยฮอร์โมนช่วยการเติบโตของพิทูอิทารี | |
| TH1618A (th) | กรรมวิธีการประดิษฐ์ออคตาเพบไทด์ซึ่งต่อต้านวาโซเพรสซิน |